Taysha Gene Therapies (NASDAQ:TSHA) Given New $9.00 Price Target at Canaccord Genuity Group
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price target boosted by Canaccord Genuity Group from $8.00 to $9.00 in a report issued on Friday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and […]
Taysha Gene Therapies (NASDAQ:TSHA – Free Report) had its price target boosted by Canaccord Genuity Group from $8.00 to $9.00 in a report issued on Friday,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. Other equities analysts have also issued reports about the stock. Cantor Fitzgerald reaffirmed an “overweight” rating and […]
